Dottikon ES Holding AG (LON:0ACK)

London flag London · Delayed Price · Currency is GBP · Price in CHF
334.63
-6.02 (-1.77%)
At close: Mar 27, 2026
Market Cap4.38B +85.7%
Revenue (ttm)403.91M +28.3%
Net Income112.86M +60.2%
EPS8.17 +60.2%
Shares Outn/a
PE Ratio38.81
Forward PE39.78
Dividendn/a
Ex-Dividend Daten/a
Volume657
Average Volume595
Open339.00
Previous Close340.65
Day's Range334.63 - 339.00
52-Week Range166.40 - 384.50
Beta1.06
RSI43.48
Earnings DateMay 29, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compound... [Read more]

Industry Industrial Organic Chemicals
Founded 1913
Employees 875
Stock Exchange London Stock Exchange
Ticker Symbol 0ACK

Financial Performance

In fiscal year 2025, Dottikon ES Holding AG's revenue was 392.68 million, an increase of 17.93% compared to the previous year's 332.98 million. Earnings were 105.58 million, an increase of 30.95%.

Financial numbers in CHF Financial Statements